Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
ACLX
ACLX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest ACLX ETF News Today | Earnings, Events & Price Alerts
ACLX News
Healthcare Stocks Show Overbought Warning Signals
2h ago
Benzinga
Investor Rights Law Firm Investigates Multiple Companies
19h ago
PRnewswire
Monteverde Law Firm Investigates Multiple Company Transactions
23h ago
Globenewswire
Arcellx Executive Sells $10.24 Million in Shares Amid Acquisition
2d ago
Fool
Monteverde Law Firm Investigates Multiple Acquisition Cases
Feb 24 2026
Globenewswire
ARCELLX INC: UBS Downgrades Rating to Neutral from Buy
Feb 24 2026
moomoo
Wall Street Analysts Adjust Ratings
Feb 24 2026
Benzinga
Wall Street Analysts Adjust Ratings
Feb 24 2026
Benzinga
Investigation into Arcellx's Proposed Sale to Gilead Sciences
Feb 24 2026
Businesswire
US Stocks Plunge as Trade Policy Concerns Emerge
Feb 24 2026
NASDAQ.COM
Investor Rights Law Firm Investigates Multiple Companies
Feb 23 2026
PRnewswire
U.S. Stocks Decline as Dow Jones Drops Over 700 Points
Feb 23 2026
Benzinga
US Stocks Plunge Sharply as Market Risk Sentiment Intensifies
Feb 23 2026
NASDAQ.COM
Financial Stocks Plummet While ImmunityBio Soars
Feb 23 2026
CNBC
US Stocks Decline Amid Trade Policy Uncertainty
Feb 23 2026
NASDAQ.COM
Ademi LLP Investigates Arcellx for Possible Fiduciary Breaches
Feb 23 2026
PRnewswire
Show More News